thr-18
Peptideexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2011 (NCT01253512)
Timeline
Indications
Studied for
Mechanism of action
- Plasminogen activator inhibitor-1INHIBITOR
SERPINE1 inhibitor
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4802182 ↗
Also known as
- thr-18
- thr-18
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02572336 | Phase 2 | Oct 1, 2015 | D-Pharm Ltd. |
| NCT01957774 | Phase 2 | Oct 1, 2013 | D-Pharm Ltd. |
| NCT01253512 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2011 | Hebrew University, Thrombotech Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| D-Pharm Ltd. | For profit | 2 | 2 | 1 | 2013 |
| Hebrew University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Thrombotech Ltd. | For profit | 1 | 1 | 1 | 2011 |
3 organizations
Page 1 / 1